These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin. Pillion DJ; Amsden JA; Kensil CR; Recchia J J Pharm Sci; 1996 May; 85(5):518-24. PubMed ID: 8742944 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of QS-21 isomers. Soltysik S; Bedore DA; Kensil CR Ann N Y Acad Sci; 1993 Aug; 690():392-5. PubMed ID: 8368766 [TBL] [Abstract][Full Text] [Related]
11. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi. Kim YJ; Wang P; Navarro-Villalobos M; Rohde BD; Derryberry J; Gin DY J Am Chem Soc; 2006 Sep; 128(36):11906-15. PubMed ID: 16953631 [TBL] [Abstract][Full Text] [Related]
12. Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria. Kensil CR; Soltysik S; Wheeler DA; Wu JY Adv Exp Med Biol; 1996; 404():165-72. PubMed ID: 8957293 [No Abstract] [Full Text] [Related]
13. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants. Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199 [TBL] [Abstract][Full Text] [Related]
14. QS-21 structure/function studies: effect of acylation on adjuvant activity. Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108 [TBL] [Abstract][Full Text] [Related]
15. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen. So HS; Yoon HS; Choi DY; Kwon YS; Sung JH; Lee TG; Park ES; Cho HS; Lee BM; Cho JM; Ryu WS Mol Cells; 1997 Apr; 7(2):178-86. PubMed ID: 9163729 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of the potent immunostimulatory adjuvant QS-21A. Wang P; Kim YJ; Navarro-Villalobos M; Rohde BD; Gin DY J Am Chem Soc; 2005 Mar; 127(10):3256-7. PubMed ID: 15755124 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant. Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932 [TBL] [Abstract][Full Text] [Related]
18. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Soltysik S; Wu JY; Recchia J; Wheeler DA; Newman MJ; Coughlin RT; Kensil CR Vaccine; 1995; 13(15):1403-10. PubMed ID: 8578817 [TBL] [Abstract][Full Text] [Related]
19. Atomic model and micelle dynamics of QS-21 saponin. Pedebos C; Pol-Fachin L; Pons R; Teixeira CV; Verli H Molecules; 2014 Mar; 19(3):3744-60. PubMed ID: 24662086 [TBL] [Abstract][Full Text] [Related]
20. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis. Fernández-Tejada A; Tan DS; Gin DY Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]